table of content
1 Introduction to Research & Analysis Reports
1.1 Artificial Intelligence Drug Development Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Intelligence Drug Development Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Intelligence Drug Development Overall Market Size
2.1 Global Artificial Intelligence Drug Development Market Size: 2022 VS 2029
2.2 Global Artificial Intelligence Drug Development Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Intelligence Drug Development Players in Global Market
3.2 Top Global Artificial Intelligence Drug Development Companies Ranked by Revenue
3.3 Global Artificial Intelligence Drug Development Revenue by Companies
3.4 Top 3 and Top 5 Artificial Intelligence Drug Development Companies in Global Market, by Revenue in 2022
3.5 Global Companies Artificial Intelligence Drug Development Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Intelligence Drug Development Players in Global Market
3.6.1 List of Global Tier 1 Artificial Intelligence Drug Development Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Intelligence Drug Development Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Artificial Intelligence Drug Development Market Size Markets, 2022 & 2029
4.1.2 Drug Design
4.1.3 Drug Synthesis
4.1.4 Other
4.2 By Type - Global Artificial Intelligence Drug Development Revenue & Forecasts
4.2.1 By Type - Global Artificial Intelligence Drug Development Revenue, 2018-2023
4.2.2 By Type - Global Artificial Intelligence Drug Development Revenue, 2024-2029
4.2.3 By Type - Global Artificial Intelligence Drug Development Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Artificial Intelligence Drug Development Market Size, 2022 & 2029
5.1.2 Tumor
5.1.3 Nervous System
5.1.4 Other
5.2 By Application - Global Artificial Intelligence Drug Development Revenue & Forecasts
5.2.1 By Application - Global Artificial Intelligence Drug Development Revenue, 2018-2023
5.2.2 By Application - Global Artificial Intelligence Drug Development Revenue, 2024-2029
5.2.3 By Application - Global Artificial Intelligence Drug Development Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Artificial Intelligence Drug Development Market Size, 2022 & 2029
6.2 By Region - Global Artificial Intelligence Drug Development Revenue & Forecasts
6.2.1 By Region - Global Artificial Intelligence Drug Development Revenue, 2018-2023
6.2.2 By Region - Global Artificial Intelligence Drug Development Revenue, 2024-2029
6.2.3 By Region - Global Artificial Intelligence Drug Development Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Artificial Intelligence Drug Development Revenue, 2018-2029
6.3.2 US Artificial Intelligence Drug Development Market Size, 2018-2029
6.3.3 Canada Artificial Intelligence Drug Development Market Size, 2018-2029
6.3.4 Mexico Artificial Intelligence Drug Development Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Artificial Intelligence Drug Development Revenue, 2018-2029
6.4.2 Germany Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.3 France Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.4 U.K. Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.5 Italy Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.6 Russia Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.7 Nordic Countries Artificial Intelligence Drug Development Market Size, 2018-2029
6.4.8 Benelux Artificial Intelligence Drug Development Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Artificial Intelligence Drug Development Revenue, 2018-2029
6.5.2 China Artificial Intelligence Drug Development Market Size, 2018-2029
6.5.3 Japan Artificial Intelligence Drug Development Market Size, 2018-2029
6.5.4 South Korea Artificial Intelligence Drug Development Market Size, 2018-2029
6.5.5 Southeast Asia Artificial Intelligence Drug Development Market Size, 2018-2029
6.5.6 India Artificial Intelligence Drug Development Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Artificial Intelligence Drug Development Revenue, 2018-2029
6.6.2 Brazil Artificial Intelligence Drug Development Market Size, 2018-2029
6.6.3 Argentina Artificial Intelligence Drug Development Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Artificial Intelligence Drug Development Revenue, 2018-2029
6.7.2 Turkey Artificial Intelligence Drug Development Market Size, 2018-2029
6.7.3 Israel Artificial Intelligence Drug Development Market Size, 2018-2029
6.7.4 Saudi Arabia Artificial Intelligence Drug Development Market Size, 2018-2029
6.7.5 UAE Artificial Intelligence Drug Development Market Size, 2018-2029
7 Artificial Intelligence Drug Development Companies Profiles
7.1 Insilico Medicine
7.1.1 Insilico Medicine Company Summary
7.1.2 Insilico Medicine Business Overview
7.1.3 Insilico Medicine Artificial Intelligence Drug Development Major Product Offerings
7.1.4 Insilico Medicine Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.1.5 Insilico Medicine Key News & Latest Developments
7.2 Cyclica
7.2.1 Cyclica Company Summary
7.2.2 Cyclica Business Overview
7.2.3 Cyclica Artificial Intelligence Drug Development Major Product Offerings
7.2.4 Cyclica Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.2.5 Cyclica Key News & Latest Developments
7.3 XtalPi Inc.
7.3.1 XtalPi Inc. Company Summary
7.3.2 XtalPi Inc. Business Overview
7.3.3 XtalPi Inc. Artificial Intelligence Drug Development Major Product Offerings
7.3.4 XtalPi Inc. Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.3.5 XtalPi Inc. Key News & Latest Developments
7.4 Exscientia Limited
7.4.1 Exscientia Limited Company Summary
7.4.2 Exscientia Limited Business Overview
7.4.3 Exscientia Limited Artificial Intelligence Drug Development Major Product Offerings
7.4.4 Exscientia Limited Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.4.5 Exscientia Limited Key News & Latest Developments
7.5 AiCure, LLC
7.5.1 AiCure, LLC Company Summary
7.5.2 AiCure, LLC Business Overview
7.5.3 AiCure, LLC Artificial Intelligence Drug Development Major Product Offerings
7.5.4 AiCure, LLC Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.5.5 AiCure, LLC Key News & Latest Developments
7.6 Atomwise
7.6.1 Atomwise Company Summary
7.6.2 Atomwise Business Overview
7.6.3 Atomwise Artificial Intelligence Drug Development Major Product Offerings
7.6.4 Atomwise Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.6.5 Atomwise Key News & Latest Developments
7.7 Biovista Inc.
7.7.1 Biovista Inc. Company Summary
7.7.2 Biovista Inc. Business Overview
7.7.3 Biovista Inc. Artificial Intelligence Drug Development Major Product Offerings
7.7.4 Biovista Inc. Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.7.5 Biovista Inc. Key News & Latest Developments
7.8 Breg?Inc.
7.8.1 Breg?Inc. Company Summary
7.8.2 Breg?Inc. Business Overview
7.8.3 Breg?Inc. Artificial Intelligence Drug Development Major Product Offerings
7.8.4 Breg?Inc. Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.8.5 Breg?Inc. Key News & Latest Developments
7.9 Numerate
7.9.1 Numerate Company Summary
7.9.2 Numerate Business Overview
7.9.3 Numerate Artificial Intelligence Drug Development Major Product Offerings
7.9.4 Numerate Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.9.5 Numerate Key News & Latest Developments
7.10 Cloud Pharmaceuticals
7.10.1 Cloud Pharmaceuticals Company Summary
7.10.2 Cloud Pharmaceuticals Business Overview
7.10.3 Cloud Pharmaceuticals Artificial Intelligence Drug Development Major Product Offerings
7.10.4 Cloud Pharmaceuticals Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.10.5 Cloud Pharmaceuticals Key News & Latest Developments
7.11 IBM
7.11.1 IBM Company Summary
7.11.2 IBM Business Overview
7.11.3 IBM Artificial Intelligence Drug Development Major Product Offerings
7.11.4 IBM Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.11.5 IBM Key News & Latest Developments
7.12 NuMedii
7.12.1 NuMedii Company Summary
7.12.2 NuMedii Business Overview
7.12.3 NuMedii Artificial Intelligence Drug Development Major Product Offerings
7.12.4 NuMedii Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.12.5 NuMedii Key News & Latest Developments
7.13 BenevolentAI
7.13.1 BenevolentAI Company Summary
7.13.2 BenevolentAI Business Overview
7.13.3 BenevolentAI Artificial Intelligence Drug Development Major Product Offerings
7.13.4 BenevolentAI Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.13.5 BenevolentAI Key News & Latest Developments
7.14 Lam Therapeutics
7.14.1 Lam Therapeutics Company Summary
7.14.2 Lam Therapeutics Business Overview
7.14.3 Lam Therapeutics Artificial Intelligence Drug Development Major Product Offerings
7.14.4 Lam Therapeutics Artificial Intelligence Drug Development Revenue in Global Market (2018-2023)
7.14.5 Lam Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
